BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. rs2230926, BRCA1, Metabolism of xenobiotics, HIV infection, Leukocyte, Tamoxifen)
Bookmark Forward

New Indication for Weight Loss Drug Semaglutide.

Diane S Aschenbrenner

The American journal of nursing 2023 Jun 01


filter terms:
  • child (1)
  • glucagon like peptides (2)
  • humans (1)
  • patients (1)
  • weight loss drug (4)
    • Sizes of these terms reflect their relevance to your search.

    The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

    Citation

    Diane S Aschenbrenner. New Indication for Weight Loss Drug Semaglutide. The American journal of nursing. 2023 Jun 01;123(6):19

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37233137

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.